Gabriel Iftime

Associate Director, Hardware Technology & Research lab

Gabriel Iftime is leading the Materials Interfaces and Processes area focused on novel materials chemistry and engineering-driven innovations in green and sustainable technologies. When working at PARC, Gabriel initiated, contributed and/or led as a PI multidisciplinary teams delivering projects in areas including controlled architected polymers applied to insulating materials, CO2 capture, sensors for detection of toxic industrial gases, and THC testing; CFRP for vehicle lightweighting, hydrogen storage; materials for electrochemical devices such as fuel cells; 3D printing; high performance polymer composites; ceramic matrix composites; nanoparticle-enabled sensors.

Previously, Gabriel was a Senior Research Scientist at the Xerox Research Center of Canada where he developed smart materials applied to reusable paper, security printing and novel marking materials for Xerox Corp. Gabriel earned his PhD from the Université Paris XI in organometallic and asymmetric synthesis, and his B.Sc/M.Sc. from the Polytechnic Institute of Bucharest in Industrial Chemistry.

Gabriel is an inventor of 200+ granted US patents and has authored 20 articles in peer-reviewed journals.

Technologies & Technical Expertise

  • Chemistry and characterization: organic, inorganic, organometallic and polymer materials
  • (Nano)-particle functionalization and formulations
  • Functional polymer aerogels
  • Polymer composites
  • Photoactive polymers
  • Curable resins, coatings
  • CO2 capture and conversion
  • Sensor materials
  • Physical & chemical hydrogen storage
  • Ionic liquids
  • Synthesis and handling air sensitive materials

Read more from SRI

  • A photo of Mary Wagner

    Recognizing the life and work of Mary Wagner 

    A cherished SRI colleague and globally respected leader in education research, Mary Wagner leaves behind an extraordinary legacy of groundbreaking work supporting children and youth with disabilities and their families.

  • Testing XRGo in a robotics laboratory

    Robots in the cleanroom

    A global health leader is exploring how SRI’s robotic telemanipulation technology can enhance pharmaceutical manufacturing.

  • SRI research aims to make generative AI more trustworthy

    Researchers have developed a new framework that reduces generative AI hallucinations by up to 32%.